Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening

Stem Cell And Neurobiology Expert Clive Svendsen, Ph.D. Joins Cedars-Sinai To Head New Regenerative Medicine Institute
Clive N. Svendsen, joint leader of the widely-respected Stem Cell and Regenerative Medicine Center at the University of Wisconsin, has been named director of the new Cedars-Sinai Regenerative Medicine Institute, effective Dec. 1, 2009.
generic viagra online
Race Plays Role In Diagnosis And Treatment
CNN reports that African Americans and whites are treated differently by doctors. "While it"s extremely difficult to tell in any given situation how much race -- consciously or unconsciously -- plays a role in a doctor"s decision making, multiple studies over several decades have found doctors make different decisions for black patients and white patients even when they have the same medical problems and the same insurance."
plastic surgery before after
News of the day
Hearing Improved In First Successful Medical Treatment For Tumor-Inducing Genetic Disorder
Treatment with the angiogenesis inhibitor bevacizumab improved hearing and alleviated other symptoms in patients with neurofibromatosis type 2 (NF2). In a paper to appear in the July 23 New England Journal of Medicine, which is receiving early online release, researchers from Massachusetts General Hospital (MGH) report that bevacizumab treatment successfully shrank characteristic tumors in a small group of NF2 patients, the first reported successful NF2 treatment not involving surgery or radiation.
Health Insurance

The New York Stem Cell Foundation Praises Final NIH Guidelines On Stem Cell Research

The New York Stem Cell Foundation (NYSCF) praised the National Institutes of Health (NIH) Final Guidelines for Human Stem Cell Research that were issued today. Susan L. Solomon, NYSCF CEO, applauded the NIH for listening carefully to the public response to its earlier draft guidelines and its willingness to make modifications in furtherance of stem cell science. "We are pleased that the NIH guidelines issued today provide a way in which funding may be considered for existing stem cell lines, on which current research is being done. President Barack Obama"s leadership on this issue, which will impact generations to come, is to be applauded." "The establishment of the stem cell registry is very important, as is the fact that much of the prescriptive language has been made more flexible," noted Kevin C. Eggan, NYSCF Chief Scientific Officer. "I remain disappointed, however, that somatic cell nuclear transfer (SCNT) and parthenogenesis derived cell lines are not eligible for federal funding and that stem cells derived from embryos created for research are also excluded. We look forward to continuing a dialogue in these areas, for the improvement of scientific advancement." "The NIH guidelines are clear, thoughtful and comprehensive - an extraordinary result, given this huge undertaking, the complexity of the issue, and the magnitude of interest from the scientific community, advocacy groups, medical organizations, and private citizens," said Zach Hall, Ph.D., a NYSCF Board Member, and former Director of the National Institute of Neurological Disorders and Stroke. "The NIH handled the guideline review process with the care and attention that the vital issue of stem cell research deserves." Solomon added, "Today"s announcement is a major step forward and we are grateful to the NIH for its efforts. We hope that the NIH and other federal policy entities will continue to foster discussion so that additional guidelines will be inclusive of all promising avenues of current research, including the creation of disease- and patient-specific human embryonic stem cell lines." The New York Stem Cell Foundation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009